CRVL

CorVel Corporation (CRVL) - 10-K Summary

Business Context and Reporting Period

Company: CorVel Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: March 31, 2009
Business Overview: CorVel is an independent nationwide provider of medical cost containment and managed care services, primarily for workers' compensation, auto insurance, and group health benefits. Services include medical fee auditing, preferred provider networks (PPO), utilization review, case management, and claims administration. The company operates in one reportable segment: managed care.

Key Financial Metrics (Fiscal Year 2009)

Material Changes vs. Prior Period

• Revenue Growth: Revenues increased 2.7% ($8.2 million) to $310.1 million. Growth was driven by Enterprise Comp and CareIQ services, offsetting a challenging market environment characterized by declining manufacturing employment and reduced workplace injuries.
• Profitability Decline: Net income decreased 17.6% to $19.3 million. Gross margin contracted from 26.0% to 23.8% due to a mix shift toward lower-margin services (Enterprise Comp and CareIQ) and increased field operating costs.
• Cost Structure: Cost of revenues increased 5.6% ($12.5 million), outpacing revenue growth. General and administrative expenses rose 6.1% ($2.4 million), primarily due to increased IT development and planning costs.
• Acquisitions: In February 2009, CorVel acquired Eagle Claims Services, Inc. for $1.1 million in cash. Eagle contributed approximately $200,000 in revenue for the fiscal year.
• Share Repurchases: The company spent $23.5 million to repurchase 995,129 shares of common stock during the fiscal year, reducing the share count and partially offsetting the decline in net income per share.

Guidance, Outlook, Risks, and Contingencies

• Internal Control Material Weakness: Management and the independent auditor identified a material weakness in internal controls over financial reporting as of March 31, 2009. Deficiencies included inadequate controls over timely reconciliation of significant accounts, use of disclosure checklists, and Excel-based consolidation processes. Remediation efforts are underway but were not fully effective at the report date.
• Legal Proceedings: A putative class action lawsuit filed in 2005 by Kathleen Roche, D.C., alleging failure to steer patients to PPO providers and use of biased software, remains pending. The trial court certified a class of Illinois healthcare providers in 2007. The company cannot estimate potential losses but intends to vigorously defend the case.
• Market Risks: The company faces headwinds from declining workers' compensation claims, price competition, and potential legislative changes in state workers' compensation laws. There is also a risk that customers may bring managed care services in-house.
• Liquidity: As of March 31, 2009, the company had no debt. In May 2009, it renewed a $10 million revolving credit facility (no borrowings outstanding). Management believes cash from operations and the credit facility are sufficient for the next 12 months.

Key Facts for Investor Verification

• Remediation of Internal Controls: Verify the progress and effectiveness of the remediation plan for the identified material weakness in financial reporting controls.
• Class Action Litigation Status: Monitor developments in the Roche class action lawsuit, as an unfavorable outcome could materially impact financial results.
• Revenue Mix Trends: Assess whether the shift toward lower-margin services (Enterprise Comp/CareIQ) continues to compress gross margins or if operational efficiencies can be realized.
• Market Volume: Track national workers' compensation claim volumes and manufacturing employment data, as these are primary drivers of CorVel's revenue.
• Stock Repurchase Program: Confirm the remaining authorization under the stock repurchase program (467,257 shares remaining as of March 31, 2009) and future buyback activity.